Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Yoshitaka Yamasaki"'
Autor:
Shuki Oya, Hidetoshi Ozawa, Takayuki Nakamura, Yoshimi Maehiro, Yusuke Takaki, Yoshinobu Fukuyama, Yoshitaka Yamasaki, Maki Yamaguchi, Kazutoshi Aoyama, Fumihiko Mouri, Koji Nagafuji
Publikováno v:
HemaSphere, Vol 7, p e53072ea (2023)
Externí odkaz:
https://doaj.org/article/66b41367bcc84ceea53108b134a79bc7
Autor:
Shuki Oya, Hidetoshi Ozawa, Yoshimi Maehiro, Takayuki Nakamura, Yusuke Takaki, Toshinobu Fukuyama, Yoshitaka Yamasaki, Maki Yamaguchi, Kazutoshi Aoyama, Fumihiko Mouri, Koji Nagafuji
Publikováno v:
Leukemia Research. 130:107313
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fc7083f413850af2fcab38180d45e24
https://doi.org/10.1016/j.leukres.2023.107313
https://doi.org/10.1016/j.leukres.2023.107313
Autor:
Kazutoshi, Aoyama, Yoshitaka, Yamasaki, Fumihiko, Mouri, Yoshimi, Maehiro, Yusuke, Takaki, Shuki, Oya, Takayuki, Nakamura, Satoshi, Morishige, Maki, Yamaguchi, Koji, Nagafuji
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 63(7)
FMS-like tyrosine kinase 3 (FLT3) inhibitors improve the prognosis of FLT3-internal tandem duplication (ITD)-positive acute myeloid leukemia (AML). Case 1 is a 47-year-old male patient who presented with a white blood cell count (WBC) of 95,700/ml wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::79199bdc5c3973c30e7cc4c7d2432555
https://pubmed.ncbi.nlm.nih.gov/35922945
https://pubmed.ncbi.nlm.nih.gov/35922945
Autor:
Kazutoshi Aoyama, Koichi Osaki, Kenta Murotani, Yoshitaka Yamasaki, Takuro Imai, Takayuki Nakamura, Maki Yamaguchi, Yusuke Takagi, Takuma Hazama, Shuki Oya, Fumihiko Mouri, Koji Nagafuji, Koichi Egashira, Satoshi Morishige
Publikováno v:
Journal of Hematopoietic Cell Transplantation. 10:129-135
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28304c4b6e11ed40d0447a2cb798ec75
https://doi.org/10.7889/hct-20-022
https://doi.org/10.7889/hct-20-022
Autor:
Shuki Oya, Hidetoshi Ozawa, Takayuki Nakamura, Toshinobu Fukuyama, Yusuke Takaki, Yoshitaka Yamasaki, Kazutoshi Aoyama, Maki Yamaguchi, Fumihiko Mouri, Koji Nagafuji
Publikováno v:
Blood. 140:11784-11785
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ae834e40ed8a45c65ab58ec691bd118
https://doi.org/10.1182/blood-2022-165800
https://doi.org/10.1182/blood-2022-165800
Autor:
Satoshi, Morishige, Yoshitaka, Yamasaki, Shuki, Oya, Takayuki, Nakamura, Maki, Yamaguchi, Kazutoshi, Aoyama, Fumihiko, Mouri, Yasuko, Mizushima, Osamu, Nakashima, Koji, Nagafuji
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 63(4)
Inotuzumab ozogamicin (InO) was administered in three cases of relapsed/refractory adult acute lymphoblastic leukemia (ALL) before allogeneic hematopoietic stem cell transplantation (allo-SCT). One case developed extremely severe sinusoidal obstructi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4da99a7d5862ebcf36b61e56a7726868
https://pubmed.ncbi.nlm.nih.gov/35491216
https://pubmed.ncbi.nlm.nih.gov/35491216
Autor:
Kazutoshi Aoyama, Ritsuko Seki, Kensuke Sasaki, Yoshitaka Yamasaki, Takahiro Maeda, Takayuki Nakamura, Shuki Oya, Hidetoshi Ozawa, Yuichiro Semba, Koji Nagafuji, Fumihiko Mouri, Koichi Osaki, Toshihiro Miyamoto, Satoshi Morishige
Publikováno v:
International Journal of Hematology. 113:285-289
BCR-ABL1-like acute lymphoblastic leukemia (ALL) is a neoplasm of lymphoblasts committed to the B-cell lineage that lack the BCR-ABL1 translocation but show a pattern of gene expression very similar to that seen in ALL with BCR-ABL1 with poor prognos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f39f5815324cbf616ccdd1a09e1ad211
https://doi.org/10.1007/s12185-020-03006-5
https://doi.org/10.1007/s12185-020-03006-5
Autor:
Fumihiko Mouri, Koichi Osaki, Koji Nagafuji, Ritsuko Seki, Kenji Kuboyama, Takayuki Nakamura, Shuki Oya, Kazutoshi Aoyama, Shinichi Mizuno, Maki Yamaguchi, Takashi Okamura, Hidetoshi Ozawa, Yoshitaka Yamasaki, Satoshi Morishige
Publikováno v:
Haemophilia. 26:826-833
Background Factor V (FV) deficiency is a monogenic inherited coagulation disorder considered to be an ideal indication for gene therapy. To investigate the possibility of therapeutic application of genome editing, we generated induced pluripotent ste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b77f24e0ace7ba34eec32532038fc3f
https://doi.org/10.1111/hae.14104
https://doi.org/10.1111/hae.14104
Autor:
Ritsuko Seki, Koichi Osaki, Shuki Oya, Takayuki Nakamura, Fumiko Arakawa, Hiroshi Saruta, Marina Nishi, Maki Yamaguchi, Satoshi Morishige, Koichi Ohshima, Kazutoshi Aoyama, Yoshitaka Yamasaki, Fumihiko Mouri, Koji Nagafuji
Publikováno v:
International Journal of Hematology. 110:506-511
Allogeneic hematopoietic cell transplantation (allo-HSCT) is considered the curative treatment option in patients with aggressive adult T cell leukemia/lymphoma (ATLL), but the treatment of relapse after allo-HSCT remains a major challenge. We report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::004b5457a9446d29b9b448242a745524
https://doi.org/10.1007/s12185-019-02675-1
https://doi.org/10.1007/s12185-019-02675-1
Autor:
Takekuni Nakama, Takayuki Nakamura, Yoshitaka Yamasaki, Hiroshi Koga, Koichi Osaki, Motohiro Morioka, Koichi Ohshima, Maki Yamaguchi, Takuya Furuta, Satoshi Morishige, Satoru Komaki, Shuki Oya, Fumihiko Mouri, Koji Nagafuji, Kazutoshi Aoyama
Publikováno v:
International journal of hematology. 114(4)
Lymphomatoid granulomatosis (LYG) is a rare Epstein-Barr virus (EBV)-driven B-cell lymphoproliferative disease affecting mainly extranodal sites such as the lung, central nervous system (CNS), skin, kidney, and liver. We report a case of low-grade LY
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae0b2d8747be47df14e1b145cec76463
https://pubmed.ncbi.nlm.nih.gov/34159518
https://pubmed.ncbi.nlm.nih.gov/34159518